Sign up
LYRA

Lyra Therapeutics Inc (NASDAQ: LYRA)

Healthcare · Biotechnology

$0.03

Last close · Nov 17, 2026 · NASDAQ USD

Set alert

The Quantellect read. Short interest is 1.43% of float with a 5.37% borrow fee. Descriptive summary of the data on this page, not a recommendation.

Relative valuationMixed valuation signals

P/S 0.8× vs peer median 13.9×

Momentum—

—

TrendBelow both averages

$0.03 vs $0.27 and $1.28 · as of Nov 17, 2026

Short interest1.4% of float

FINRA settlement Oct 30, 2026

LYRA price chart

Price $0.03 · As of Nov 18, 2026, 8:46 PM ET

Open full chart →
Nov 17, 2026O $0.03H $0.03L $0.03C $0.03Vol 266

Chart loads when this section enters view.

Text price and event history
6M plotted price range (ET)
Range6M
First dateMay 18, 2026 ET
Last dateNov 17, 2026 ET
Open$0.70
High$0.88
Low$0.00
Close$0.03
Volume682,353
Plotted bars78

Plotted OHLCV bars

  1. May 18, 2026 ET · Open $0.70 · High $0.70 · Low $0.65 · Close $0.65 · Volume 6,179
  2. May 19, 2026 ET · Open $0.65 · High $0.75 · Low $0.65 · Close $0.74 · Volume 7,111
  3. May 20, 2026 ET · Open $0.75 · High $0.75 · Low $0.73 · Close $0.73 · Volume 11,033
  4. May 21, 2026 ET · Open $0.70 · High $0.75 · Low $0.70 · Close $0.70 · Volume 2,496
  5. May 22, 2026 ET · Open $0.88 · High $0.88 · Low $0.65 · Close $0.75 · Volume 18,321
  6. May 26, 2026 ET · Open $0.70 · High $0.75 · Low $0.70 · Close $0.70 · Volume 3,159
  7. May 27, 2026 ET · Open $0.74 · High $0.78 · Low $0.70 · Close $0.78 · Volume 6,131
  8. May 28, 2026 ET · Open $0.72 · High $0.72 · Low $0.70 · Close $0.70 · Volume 1,278
  9. May 29, 2026 ET · Open $0.72 · High $0.75 · Low $0.72 · Close $0.74 · Volume 2,838
  10. Jun 1, 2026 ET · Open $0.75 · High $0.75 · Low $0.70 · Close $0.70 · Volume 1,842
  11. Jun 2, 2026 ET · Open $0.70 · High $0.75 · Low $0.70 · Close $0.70 · Volume 4,131
  12. Jun 3, 2026 ET · Open $0.70 · High $0.70 · Low $0.65 · Close $0.66 · Volume 20,831
  13. Jun 4, 2026 ET · Open $0.70 · High $0.70 · Low $0.69 · Close $0.69 · Volume 11,097
  14. Jun 5, 2026 ET · Open $0.70 · High $0.71 · Low $0.70 · Close $0.70 · Volume 1,058
  15. Jun 8, 2026 ET · Open $0.70 · High $0.70 · Low $0.70 · Close $0.70 · Volume 5,288
  16. Jun 9, 2026 ET · Open $0.65 · High $0.80 · Low $0.65 · Close $0.80 · Volume 2,058
  17. Jun 10, 2026 ET · Open $0.70 · High $0.75 · Low $0.55 · Close $0.60 · Volume 88,159
  18. Jun 11, 2026 ET · Open $0.75 · High $0.75 · Low $0.60 · Close $0.60 · Volume 3,102
  19. Jun 12, 2026 ET · Open $0.60 · High $0.71 · Low $0.55 · Close $0.55 · Volume 40,506
  20. Jun 15, 2026 ET · Open $0.55 · High $0.65 · Low $0.55 · Close $0.65 · Volume 3,622
  21. Jun 16, 2026 ET · Open $0.63 · High $0.69 · Low $0.60 · Close $0.69 · Volume 1,377
  22. Jun 18, 2026 ET · Open $0.60 · High $0.68 · Low $0.60 · Close $0.68 · Volume 232
  23. Jun 22, 2026 ET · Open $0.60 · High $0.65 · Low $0.44 · Close $0.57 · Volume 84,579
  24. Jun 23, 2026 ET · Open $0.65 · High $0.65 · Low $0.56 · Close $0.56 · Volume 10,725
  25. Jun 24, 2026 ET · Open $0.58 · High $0.58 · Low $0.58 · Close $0.58 · Volume 309
  26. Jun 26, 2026 ET · Open $0.60 · High $0.60 · Low $0.60 · Close $0.60 · Volume 355
  27. Jun 29, 2026 ET · Open $0.60 · High $0.60 · Low $0.60 · Close $0.60 · Volume 756
  28. Jun 30, 2026 ET · Open $0.64 · High $0.70 · Low $0.60 · Close $0.70 · Volume 22,214
  29. Jul 1, 2026 ET · Open $0.62 · High $0.63 · Low $0.60 · Close $0.62 · Volume 6,053
  30. Jul 2, 2026 ET · Open $0.65 · High $0.71 · Low $0.65 · Close $0.71 · Volume 178
  31. Jul 7, 2026 ET · Open $0.55 · High $0.65 · Low $0.50 · Close $0.60 · Volume 148,958
  32. Jul 8, 2026 ET · Open $0.60 · High $0.60 · Low $0.51 · Close $0.51 · Volume 15,603
  33. Jul 9, 2026 ET · Open $0.51 · High $0.54 · Low $0.51 · Close $0.54 · Volume 10,755
  34. Jul 10, 2026 ET · Open $0.54 · High $0.54 · Low $0.54 · Close $0.54 · Volume 280
  35. Jul 13, 2026 ET · Open $0.48 · High $0.50 · Low $0.48 · Close $0.48 · Volume 11,082
  36. Jul 14, 2026 ET · Open $0.59 · High $0.65 · Low $0.31 · Close $0.37 · Volume 47,246
  37. Jul 15, 2026 ET · Open $0.55 · High $0.58 · Low $0.38 · Close $0.52 · Volume 9,248
  38. Jul 16, 2026 ET · Open $0.30 · High $0.58 · Low $0.30 · Close $0.57 · Volume 3,780
  39. Jul 17, 2026 ET · Open $0.45 · High $0.52 · Low $0.36 · Close $0.52 · Volume 12
  40. Jul 23, 2026 ET · Open $0.00 · High $0.52 · Low $0.00 · Close $0.52 · Volume 415
  41. Jul 27, 2026 ET · Open $0.50 · High $0.50 · Low $0.50 · Close $0.50 · Volume 2,000
  42. Jul 29, 2026 ET · Open $0.48 · High $0.48 · Low $0.48 · Close $0.48 · Volume 204
  43. Aug 5, 2026 ET · Open $0.45 · High $0.45 · Low $0.11 · Close $0.40 · Volume 1,131
  44. Aug 7, 2026 ET · Open $0.35 · High $0.35 · Low $0.33 · Close $0.34 · Volume 990
  45. Aug 10, 2026 ET · Open $0.40 · High $0.40 · Low $0.27 · Close $0.28 · Volume 11,261
  46. Aug 11, 2026 ET · Open $0.25 · High $0.25 · Low $0.25 · Close $0.25 · Volume 109
  47. Aug 12, 2026 ET · Open $0.25 · High $0.25 · Low $0.25 · Close $0.25 · Volume 141
  48. Aug 13, 2026 ET · Open $0.15 · High $0.25 · Low $0.15 · Close $0.25 · Volume 832
  49. Aug 17, 2026 ET · Open $0.00 · High $0.25 · Low $0.00 · Close $0.24 · Volume 621
  50. Aug 18, 2026 ET · Open $0.02 · High $0.04 · Low $0.02 · Close $0.04 · Volume 5,235
  51. Aug 19, 2026 ET · Open $0.00 · High $0.00 · Low $0.00 · Close $0.00 · Volume 555
  52. Aug 20, 2026 ET · Open $0.00 · High $0.00 · Low $0.00 · Close $0.00 · Volume 815
  53. Aug 24, 2026 ET · Open $0.01 · High $0.01 · Low $0.01 · Close $0.01 · Volume 119
  54. Aug 25, 2026 ET · Open $0.01 · High $0.01 · Low $0.01 · Close $0.01 · Volume 1,046
  55. Aug 31, 2026 ET · Open $0.01 · High $0.01 · Low $0.01 · Close $0.01 · Volume 1,011
  56. Sep 2, 2026 ET · Open $0.01 · High $0.20 · Low $0.01 · Close $0.20 · Volume 456
  57. Sep 8, 2026 ET · Open $0.03 · High $0.19 · Low $0.03 · Close $0.19 · Volume 224
  58. Sep 9, 2026 ET · Open $0.20 · High $0.20 · Low $0.20 · Close $0.20 · Volume 110
  59. Sep 16, 2026 ET · Open $0.03 · High $0.20 · Low $0.03 · Close $0.20 · Volume 2,206
  60. Sep 21, 2026 ET · Open $0.05 · High $0.20 · Low $0.05 · Close $0.20 · Volume 1,118
  61. Sep 22, 2026 ET · Open $0.05 · High $0.20 · Low $0.05 · Close $0.20 · Volume 600
  62. Sep 24, 2026 ET · Open $0.03 · High $0.20 · Low $0.03 · Close $0.03 · Volume 2,004
  63. Sep 25, 2026 ET · Open $0.20 · High $0.20 · Low $0.20 · Close $0.20 · Volume 213
  64. Sep 30, 2026 ET · Open $0.03 · High $0.03 · Low $0.03 · Close $0.03 · Volume 341
  65. Oct 1, 2026 ET · Open $0.03 · High $0.15 · Low $0.03 · Close $0.15 · Volume 2,678
  66. Oct 2, 2026 ET · Open $0.15 · High $0.15 · Low $0.15 · Close $0.15 · Volume 348
  67. Oct 5, 2026 ET · Open $0.14 · High $0.19 · Low $0.14 · Close $0.19 · Volume 317
  68. Oct 8, 2026 ET · Open $0.03 · High $0.20 · Low $0.03 · Close $0.20 · Volume 2,102
  69. Oct 9, 2026 ET · Open $0.03 · High $0.19 · Low $0.03 · Close $0.19 · Volume 2,100
  70. Oct 12, 2026 ET · Open $0.00 · High $0.20 · Low $0.00 · Close $0.19 · Volume 1,637
  71. Oct 13, 2026 ET · Open $0.05 · High $0.19 · Low $0.05 · Close $0.19 · Volume 420
  72. Oct 19, 2026 ET · Open $0.03 · High $0.19 · Low $0.03 · Close $0.19 · Volume 4,321
  73. Oct 27, 2026 ET · Open $0.03 · High $0.19 · Low $0.03 · Close $0.19 · Volume 10,110
  74. Nov 2, 2026 ET · Open $0.03 · High $0.19 · Low $0.03 · Close $0.19 · Volume 403
  75. Nov 5, 2026 ET · Open $0.03 · High $0.19 · Low $0.03 · Close $0.19 · Volume 401
  76. Nov 12, 2026 ET · Open $0.00 · High $0.20 · Low $0.00 · Close $0.19 · Volume 1,372
  77. Nov 16, 2026 ET · Open $0.03 · High $0.03 · Low $0.03 · Close $0.03 · Volume 8,139
  78. Nov 17, 2026 ET · Open $0.03 · High $0.03 · Low $0.03 · Close $0.03 · Volume 266

Event records

Event records load after the price chart.

Split-adjusted daily prices · Price as of Nov 18, 2026, 8:46 PM ET

Initial 6M price range summary
Range6M
First close$0.65
Last close$0.03
High$0.88
Low$0.00
Volume682,353
Open
—Historical · Nov 17, 2026
Previous close
—Historical · Nov 17, 2026
Day range
—Historical · Nov 17, 2026
52-week range
—Through Nov 18, 2026
Volume
—Historical · Nov 17, 2026
Average volume (30 calendar days, 7 sessions)
3.57KThrough Nov 18, 2026
Market cap$337.23K
P/E (TTM)negative earnings —
Forward P/E—
EPS (TTM)stale vendor snapshot —
Dividend yielddata unavailable —
Beta (5-year monthly vs SPY)0.01

Price history

LYRA · nasdaq · USD

Last completed session: Nov 17, 2026

Split-adjusted · volume in shares

Missing sessions: Nov 3, 2026, Nov 4, 2026, Nov 6, 2026, Nov 9, 2026, Nov 10, 2026, Nov 11, 2026, Nov 13, 2026, Nov 18, 2026

November 2026 · 5 completed sessions
DateOpenHighLowCloseChangeVolume
0.030.030.030.030.000.00%266
Open 0.03High 0.03Low 0.03
0.030.030.030.03—8,139
Open 0.03High 0.03Low 0.03
0.00040.1950.00040.19—1,372
Open 0.0004High 0.195Low 0.0004
0.030.190.030.19—401
Open 0.03High 0.19Low 0.03
0.030.190.030.19—403
Open 0.03High 0.19Low 0.03

Notable price movement

Sessions where the close moved at least twice its average daily move of the prior 20 sessions (minimum 3%), or 10% or more.

  1. $0.03−84.21%

    Trading volume was 2.5 times the 30-day average, with 8.14K shares traded.

  2. $0.19+26.67%

    Trading volume was 0.3 times the 30-day average, with 317 shares traded.

  3. $0.15+400.00%

    Trading volume was 3.3 times the 30-day average, with 2.68K shares traded.

Options flow

— · Options flow not available

Q Score

— · Q Score not available

Quantellect signals

Change since Nov 18

Insufficient data · Tide session Nov 18, 2026

Tide39Calm Tide—
Squeeze16Idle—
How the scores work →

How LYRA compares with its industry

Against 592 other US-listed Biotechnology stocks

Dot = rank among peers, low to high · tick = peer median · colour marks the top and bottom 10%

Points of caution

  1. One-month return was -84.2%, with only 1% of 567 peers reporting a lower value.Peer median −13.8% · As of Nov 16, 2026
  2. Latest-quarter year-over-year sales growth was -96.7%, with only 10% of 592 peers reporting a lower value.Peer median 0.0% · As of Nov 17, 2026
  3. Trailing-year net margin was 0%, with only 19% of 583 peers reporting a lower value.Peer median 0.0% · As of Nov 17, 2026

Valuation

Mixed valuation signals

  • Price/sales0.85×13.90×
    Lowest 10%

    Higher than 6% of 407 peers

  • Forward P/E—14.90×

    Not ranked: only 194 of 592 peers report it

  • Price/book7.10×2.57×

    Higher than 79% of 551 peers

Profitability

Profitability metrics are lower than most peers.

  • Gross margin—78.4%

    Not ranked: only 247 of 592 peers report it

  • Operating margin—0.0%

    Not ranked: only 443 of 592 peers report it

  • Net margin0.0%0.0%

    Higher than 19% of 583 peers

  • Return on equity—−67.9%

    Not ranked: only 555 of 592 peers report it

Growth

Growth metrics are lower than most peers.

  • Quarterly sales growth, year over year−96.7%0.0%
    Bottom 10% of peers

    Higher than 10% of 592 peers

  • 5-year sales growth rate—11.3%

    Not ranked: only 140 of 592 peers report it

Balance sheet

Not enough peers report balance sheet metrics for a group comparison.

  • Current ratio—5.01

    Not ranked: only 499 of 592 peers report it

  • Debt/equity (total borrowings)—0.23

    Not ranked: only 117 of 592 peers report it

Momentum

Not enough peers report returns for a group comparison.

  • 1-year return—−28.4%

    Not ranked: only 523 of 592 peers report it

  • 6-month return—−26.6%

    Not ranked: only 546 of 592 peers report it

  • 3-month return—−29.8%

    Not ranked: only 559 of 592 peers report it

Compared with 592 other US-listed Biotechnology stocks · fundamentals as of Nov 1, 2026 · prices as of Nov 13, 2026

Upcoming events

— · Upcoming events not available

Analyst consensus

— · Analyst consensus not available

Earnings history

EPS, last 8 quarters
EstimateBeatMissMatch
Fiscal periodEst.ActualResult
Annual 2025—−$18.62—
Q3 2025—−$3.38—
Q2 2025—−$5.51—
Q1 2025—−$0.13—
Annual 2024−$0.13−$1.43—
Q3 2024−$10.25−$0.18—
Q2 2024−$16.40−$0.74—
Q1 2024−$13.40−$0.35—

Smart-money activity

In the last 60 days: 0 insider sales and 0 purchases. No congressional trades in 90 days.

DateTypeWhoActionAmountSource
Insider sellCavalier JasonSell$2.6KForm 4
Insider sellPalasis MariaSell$5.7KForm 4
Insider sellPERCEPTIVE ADVISORS LLC / PERCEPTIVE LIFE SCIENCES MASTER FUND LTD / Perceptive LS (A), LLC / EDELMAN JOSEPHSell$12.5KForm 4
Insider sellPERCEPTIVE ADVISORS LLC / PERCEPTIVE LIFE SCIENCES MASTER FUND LTD / Perceptive LS (A), LLC / EDELMAN JOSEPHSell$111.5KForm 4
Insider sellPERCEPTIVE ADVISORS LLC / PERCEPTIVE LIFE SCIENCES MASTER FUND LTD / Perceptive LS (A), LLC / EDELMAN JOSEPHSell$3.6KForm 4
Insider sellPERCEPTIVE ADVISORS LLC / PERCEPTIVE LIFE SCIENCES MASTER FUND LTD / Perceptive LS (A), LLC / EDELMAN JOSEPHSell$31.9KForm 4
Insider sellPERCEPTIVE ADVISORS LLC / PERCEPTIVE LIFE SCIENCES MASTER FUND LTD / Perceptive LS (A), LLC / EDELMAN JOSEPHSell$2.3KForm 4
Insider sellPERCEPTIVE ADVISORS LLC / PERCEPTIVE LIFE SCIENCES MASTER FUND LTD / Perceptive LS (A), LLC / EDELMAN JOSEPHSell$20.6KForm 4
Insider sellPERCEPTIVE ADVISORS LLC / PERCEPTIVE LIFE SCIENCES MASTER FUND LTD / Perceptive LS (A), LLC / EDELMAN JOSEPHSell$8.5KForm 4
Insider sellPERCEPTIVE ADVISORS LLC / PERCEPTIVE LIFE SCIENCES MASTER FUND LTD / Perceptive LS (A), LLC / EDELMAN JOSEPHSell$75.5KForm 4
All smart-money activity →

News and press releases

All LYRA news →

Company profile

Lyra Therapeutics, Inc., a clinical-stage biotechnology company, focuses on the development and commercialization of anti-inflammatory therapies for the treatment of patients with chronic rhinosinusitis. Its technology is designed to deliver medicines directly to the affected tissue for sustained periods with a single administration. The company's product candidates include LYR-210, an anti-inflammatory implantable drug matrix which is in Phase III clinical trial for the treatment of chronic

CEO
—
Headquarters
Watertown, MA, United States
Employees
27
IPO date
May 1, 2020
Sector
Healthcare
Industry
Biotechnology

Data sources: exchange quotes delayed 15 minutes, FINRA short interest, SEC filings, OPRA options data and third-party analyst data. Education only. Nothing on this page is a recommendation to buy or sell a security.